NASDAQ · Drug Manufacturers - Specialty & Generic
ANIP (ANIP) Stock
$82.63
+3.44%
NASDAQ: ANIP
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
2 Value Stocks for Long-Term Investors and 1 We Avoid
StockStory · Jul 10, 2026
ANI Pharmaceuticals CFO Sells $240,000 in Stock After a 42% Cortrophin Surge
Motley Fool · Jul 9, 2026
3 of Wall Street’s Favorite Stocks to Target This Week
StockStory · Jul 6, 2026
How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks?
Barchart · Jun 19, 2026
Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?
Zacks · Jun 10, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held5.55%
Institutions Held110.29%
Institutions Float Held116.77%
Peer Comparison
About ANIP
ANIP stock trades at $82.63 with a market capitalization of $1.88B. The stock is valued at a price-to-earnings (P/E) ratio of 24.92, price-to-book of 3.48, price-to-sales of 2.04. Over the past 52 weeks the stock has ranged between $56.71 and $99.50, and currently trades 17.0% below its 52-week high.
On profitability, ANIP generates a return on equity (ROE) of 14.42%, above the typical market average, return on capital employed of 15.00%, an operating margin of 9.17%, a net profit margin of 9.71%.